Selectis Health Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Selectis Health Inc (GBCS) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Selectis Health Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 33M vs 3,124M combined for its competitors (1.0% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-41.9% annualized vs trailing 12 months), vs decelerating (-2.2%) for its tracked peer group.
- Growth: Selectis Health Inc generated -54.7% revenue growth year over year in Q2 2026, vs -1.7% for its competitors combined.
- Profitability: Its 171.9% net margin compares with -1.9% for the peer group.
- Peer revenue share: Selectis Health Inc accounted for 0.6% of combined revenue among its tracked peer group, down from 1.3% a year earlier.
- Peer differentiation: Revenue per employee of $0.07M compares with $0.49M for the peer group (0.1x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
GBCS Sales vs. its Competitors, Q2 2026
Selectis Health Inc reported revenue contraction of 54.73 % year on year in Q2 2026, below its competitors' combined revenue change of -1.73 %.
With a net margin of 171.85 %, Selectis Health Inc achieved higher profitability than its competitors (-1.91 %).
Selectis Health Inc generated 0.62 % of the combined sales of its peer group, down from 1.33 % a year earlier.
API endpoints for this dataset
Selectis Health Inc vs. its Competitors, Q2 2026
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in Selectis Health Inc reports; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Selectis Health Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Selectis Health Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Selectis Health Inc's competitor groups requires a Commercial License.
For context: the Real Estate Investment Trusts industry grew revenue -1.0% year over year, combined, vs -54.7% for Selectis Health Inc. Selectis Health Inc's share of combined industry revenue moved from 0.01% to 0.01%, a loss of 0.01 percentage points.
Selectis Health Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Selectis Health Inc | - | - | - | No |
| Competitors combined (2) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
GBCS Stock Performance relative to its Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Teladoc Health Inc | 282.9% | Outperformed |
| 2 | Doximity Inc | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Selectis Health Inc's best-performing competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Selectis Health Inc's Comment on Competition and Industry Peers
Publicly Traded Peers of Selectis Health Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 Selectis Health Inc |
19.80 | 32.53 |
 Doximity Inc |
6,283.73 | 656.04 |
 Teladoc Health Inc |
1,633.25 | 2,468.14 |
| SUBTOTAL | 7,936.77 | 3,156.71 |
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Selectis Health Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Selectis Health Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Teladoc Health Inc | Teladoc Health Integrated Care 65.85 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Selectis Health Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Selectis Health Inc | 20 | 68,337 | 30,668 |
| Doximity Inc | 6,284 | 790,404 | 201,260 |
| Teladoc Health Inc | 1,633 | 440,740 | -27,647 |
| PEERS TOTAL | 7,917 | 485,875 | 1,901 |
Selectis Health Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent report. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Teladoc Health Inc | United States 80.85 % |
Source: revenue geography as reported in each company's reports (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Selectis Health Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 181 companies in Selectis Health Inc's industry classification, broader than the peer set above. Market cap in millions of $.Selectis Health Inc ranks #0 of 181 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 414, indicating a unconcentrated market structure (see Methodology: Market Structure & Concentration).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Welltower Inc | 182,533 | 11.96 % |
| 2 | Prologis Inc | 125,052 | 8.19 % |
| 3 | Equinix Inc | 104,539 | 6.85 % |
| 4 | American Tower Corporation | 88,124 | 5.77 % |
| 5 | Simon Property Group inc | 1,234 | 5.2% |
| 6 | Digital Realty Trust Inc | 1,234 | 5.2% |
| 7 | Public Storage | 1,234 | 5.2% |
| 8 | Realty Income Corporation | 1,234 | 5.2% |
| 9 | Ventas inc | 1,234 | 5.2% |
| 10 | Crown Castle Inc | 1,234 | 5.2% |
| 0 | Selectis Health Inc | 20 | 0.00 % |
Market cap and industry share for the rest of Selectis Health Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-10-06.
Selectis Health Inc's Valuation vs Competitive Position
Valuation multiples vs the Real Estate Investment Trusts industry average (283 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Real Estate Investment Trusts industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | 0.9x | 30.1x | -29.2x |
| EV / EBITDA | 2.1x | 17.5x | -15.3x |
| P/B | -14.5x | 1.9x | -16.3x |
| Return on Equity | - | industry aggregate | - |
| Return on Invested Capital | - | 2.09 % (avg) | - |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Selectis Health Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth | 15.77 % | 91.26 % | 202.00 % | - | - | -9.40 % | 7.36 % | 4.94 % |
| Operating Margin | 13.11 % | 18.77 % | 16.13 % | - | -0.71 % | -24.36 % | -6.91 % | -3.78 % |
| Return on Invested Capital | 14.22 % | 45.46 % | 92.95 % | -1.96 % | -0.73 % | -28.82 % | -21.85 % | -29.31 % |
| P/E | - | - | - | - | - | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Selectis Health Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | High | Industry HHI of 414 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | Lower than typical for the industry | Capital intensity (capex / revenue) of 1.44 % vs industry average 28.42 % (see Profitability & Cost Structure above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on Selectis Health Inc's dedicated Suppliers and Customers pages, not here.
Selectis Health Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
No rule matched.
Weaknesses
- Latest-quarter revenue run-rate is decelerating (-41.9% annualized vs trailing 12 months).
Opportunities
No rule matched.
Threats
- Tracked peer group's revenue run-rate is broadly decelerating (-2.2% annualized).
Methodology: see Methodology: SWOT Analysis.
Selectis Health Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Selectis Health Inc | 0.14 | 0.45 | - |
| Doximity Inc | 1.45 | 6.71 | - |
| Teladoc Health Inc | 0.88 | 1.28 | 0.75 |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Selectis Health Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Selectis Health Inc | Q2 2026 | -54.7 % | - |
| Doximity Inc | Q2 2026 | +7.9 % | -54.4 % |
| Teladoc Health Inc | Q3 2026 | -3.4 % | - |
| PEERS TOTAL | -2.0 % | +57.0 % |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Selectis Health Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Selectis Health Inc | Q2 2026 | - | -80.7 % |
| Doximity Inc | Q2 2026 | +57.9 % | +21.3 % |
| Teladoc Health Inc | Q3 2026 | +1.6 % | -2.5 % |
Selectis Health Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Selectis Health Inc | 45.87% | 126.06% | - |
| Doximity Inc | 14.13% | 16.19% | 16.52% |
| Teladoc Health Inc | - | - | - |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Selectis Health Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Selectis Health Inc | 1.36 | 0.61 |
| Doximity Inc | 38.69 | 9.58 |
| Teladoc Health Inc | - | 0.66 |
| PEERS AVERAGE | 295.91 | 2.51 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.